Clinical trial
South Australian Meningococcal B Vaccine Herd Immunity Study
NCT03089086 is registered in ClinicalTrials.gov with University of Adelaide as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- South Australian Meningococcal B Vaccine Herd Immunity Study
- Lead sponsor
- University of Adelaide
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2017
- Completion date
- December 31, 2018
- Enrollment
- 34,489 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
meningococcal disease